-
1 Comment
Beijing Science Sun Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 16.9% below its 200 day moving average.
From a valuation standpoint, the stock is 49.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.
Beijing Science Sun Pharmaceutical Co., Ltd's total revenue sank by 2.9% to $303M since the same quarter in the previous year.
Its net income has increased by 17.5% to $26M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Beijing Science Sun Pharmaceutical Co., Ltd gets an overall score of 2/5.
ISIN | CNE100002110 |
---|---|
Sector | Healthcare |
Exchange | SHE |
CurrencyCode | CNY |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 4B |
---|---|
PE Ratio | 23.71 |
Target Price | None |
Beta | 0.04 |
Dividend Yield | 0.3% |
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sales of injections in China. It offers products for cardiovascular, cerebrovascular, immunomodulation, nervous systems, and other varieties. The company is also engaged in the research, development, production, and sale of raw materials; extraction of traditional Chinese medicine; and the manufacture of Chinese and Western medicine preparations. In addition, it is involved in breeding livestock and poultry production; research, development, and sale of bio-organic fertilizer; and research and development of bio-feed. Further, the company provides consulting services; venture capital activities; and equity investment with private equity funds. The company was founded in 1999 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300485.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025